136 related articles for article (PubMed ID: 38829652)
1. One person, many changes: a socioecological qualitative analysis of the experiences of transfeminine individuals undergoing feminising gender-affirming hormone therapy.
Fowler JA; Warzywoda S; Reyment M; Crilly T; Franks N; Bisshop F; Wood P; Dean JA
Cult Health Sex; 2024 Jun; ():1-17. PubMed ID: 38829652
[TBL] [Abstract][Full Text] [Related]
2. Barriers and Facilitators to Gender-affirming Hormone Therapy in the Veterans Health Administration.
Wolfe HL; Boyer TL; Shipherd JC; Kauth MR; Jasuja GK; Blosnich JR
Ann Behav Med; 2023 Nov; 57(12):1014-1023. PubMed ID: 37436725
[TBL] [Abstract][Full Text] [Related]
3. Highs, Lows, and Hormones: A Qualitative Metasynthesis of Transgender Individuals' Experiences Undergoing Gender-Affirming Hormone Therapy.
Fowler JA; Warzywoda S; Franks N; Mendis M; Lazarou M; Bisshop F; Wood P; Dean JA
J Homosex; 2024 Jun; 71(7):1652-1683. PubMed ID: 36884002
[TBL] [Abstract][Full Text] [Related]
4. Short-Term Effects of Gender-Affirming Hormone Therapy on Dysphoria and Quality of Life in Transgender Individuals: A Prospective Controlled Study.
Foster Skewis L; Bretherton I; Leemaqz SY; Zajac JD; Cheung AS
Front Endocrinol (Lausanne); 2021; 12():717766. PubMed ID: 34394009
[TBL] [Abstract][Full Text] [Related]
5. Longitudinal Changes in Liver Enzyme Levels Among Transgender People Receiving Gender Affirming Hormone Therapy.
Hashemi L; Zhang Q; Getahun D; Jasuja GK; McCracken C; Pisegna J; Roblin D; Silverberg MJ; Tangpricha V; Vupputuri S; Goodman M
J Sex Med; 2021 Sep; 18(9):1662-1675. PubMed ID: 34366264
[TBL] [Abstract][Full Text] [Related]
6. Feminizing gender-affirming hormone therapy for the transgender and gender diverse population: An overview of treatment modality, monitoring, and risks.
Sudhakar D; Huang Z; Zietkowski M; Powell N; Fisher AR
Neurourol Urodyn; 2023 Jun; 42(5):903-920. PubMed ID: 36403287
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of and factors associated with the use of gender-affirming hormonal therapy outside the reference regimen among transgender people in a community-led clinic in Metro Manila, Philippines: a retrospective cross-sectional study.
Eustaquio PC; Dela Cruz JDM; Araña Y; Rosos B; Rosadiño JDT; Pagtakhan RG; Regencia ZJG; Baja ES
BMJ Open; 2023 Sep; 13(9):e072252. PubMed ID: 37669846
[TBL] [Abstract][Full Text] [Related]
8. Which U.S. States' Medicaid Programs Provide Coverage for Gender-Affirming Hormone Therapy and Gender-Affirming Genital Surgery for Transgender Patients?: A State-by-State Review, and a Study Detailing the Patient Experience to Confirm Coverage of Services.
Zaliznyak M; Jung EE; Bresee C; Garcia MM
J Sex Med; 2021 Feb; 18(2):410-422. PubMed ID: 33422448
[TBL] [Abstract][Full Text] [Related]
9. A Proposed Inventory to Assess Changes in Orgasm Function of Transgender Patients Following Gender Affirming Treatments: Pilot Study.
Zaliznyak M; Lauzon M; Stelmar J; Yuan N; Smith SM; Garcia MM
Sex Med; 2022 Jun; 10(3):100510. PubMed ID: 35472753
[TBL] [Abstract][Full Text] [Related]
10. Changes in depression symptom profile with gender-affirming hormone use in transgender persons.
Morssinkhof MWL; Wiepjes CM; van den Heuvel OA; Kreukels BPC; van der Tuuk K; T'Sjoen G; den Heijer M; Broekman BFP
J Affect Disord; 2024 Mar; 348():323-332. PubMed ID: 38154588
[TBL] [Abstract][Full Text] [Related]
11. Gender-Affirming Hormone Therapy: Physical and Sociopsychological Effects, Impact and Satisfaction.
Santos RB; Lemos C; Saraiva M
Cureus; 2023 Mar; 15(3):e36484. PubMed ID: 37090416
[TBL] [Abstract][Full Text] [Related]
12. Effects of gender affirming hormone therapy on body mass index in transgender individuals: A longitudinal cohort study.
Suppakitjanusant P; Ji Y; Stevenson MO; Chantrapanichkul P; Sineath RC; Goodman M; Alvarez JA; Tangpricha V
J Clin Transl Endocrinol; 2020 Sep; 21():100230. PubMed ID: 32685379
[TBL] [Abstract][Full Text] [Related]
13. Hyperprolactinemia and association with prolactinoma in transwomen receiving gender affirming hormone treatment.
Raven LM; Guttman-Jones M; Muir CA
Endocrine; 2021 May; 72(2):524-528. PubMed ID: 33398769
[TBL] [Abstract][Full Text] [Related]
14. Gender-affirming hormone therapy induces specific DNA methylation changes in blood.
Shepherd R; Bretherton I; Pang K; Mansell T; Czajko A; Kim B; Vlahos A; Zajac JD; Saffery R; Cheung A; Novakovic B
Clin Epigenetics; 2022 Feb; 14(1):24. PubMed ID: 35177097
[TBL] [Abstract][Full Text] [Related]
15. Laboratory Changes During Gender-Affirming Hormone Therapy in Transgender Adolescents.
Millington K; Lee JY; Olson-Kennedy J; Garofalo R; Rosenthal SM; Chan YM
Pediatrics; 2024 May; 153(5):. PubMed ID: 38567424
[TBL] [Abstract][Full Text] [Related]
16. New Insights Into Extended Steroid Hormone Profiles in Transwomen in a Multi-Center Setting in Germany.
Schneider F; Wistuba J; Holterhus PM; Kulle A; Schlatt S; Kliesch S; Neuhaus N; Zitzmann M
J Sex Med; 2021 Oct; 18(10):1807-1817. PubMed ID: 34600646
[TBL] [Abstract][Full Text] [Related]
17. Effects of gender affirming hormone treatment in transgender individuals - a retrospective cohort study.
Muir CA; Guttman-Jones M; Man EJ
Endocrine; 2024 Feb; ():. PubMed ID: 38386168
[TBL] [Abstract][Full Text] [Related]
18. Hormone Concentrations in Transgender Women Who Self-Prescribe Gender Affirming Hormone Therapy: A Retrospective Study.
Salakphet T; Mattawanon N; Manojai N; Muangmool T; Tangpricha V
J Sex Med; 2022 May; 19(5):864-871. PubMed ID: 35379590
[TBL] [Abstract][Full Text] [Related]
19. The Real-World Characteristics of Gender-Affirming Hormonal Use Among Transgender People in Thailand.
Ittiphisit S; Amponnavarat S; Manaboriboon N; Korpaisarn S
Sex Med; 2022 Jun; 10(3):100513. PubMed ID: 35428019
[TBL] [Abstract][Full Text] [Related]
20. Gender minority stress in transgender people: a major role for social network.
Collet S; Kiyar M; Martens K; Vangeneugden J; Simpson VG; Guillamon A; Mueller SC; T'Sjoen G
J Sex Med; 2023 May; 20(6):905-917. PubMed ID: 37102304
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
